Deciphering the “Collagen code” in tumor progression
- 1 January 2021
- journal article
- review article
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 17 (1), 29-32
- https://doi.org/10.4103/jcrt.jcrt_489_17
Abstract
Invasion and metastasis are the fundamental properties of tumor biology and the root causes of cancer death. With the elucidation of genetic and epigenetic mechanisms, it has been postulated that cancer is a disease of imbalance. It is not merely a disease of tumor cells but also the body's mismanagement of those tumor cells. Tumor microenvironment plays an important role in tumor progression via the co-evolution of tumor cells and tumor stroma. Hence, exploring the complex mechanisms of tumor progression from perspectives of tumor stroma has become a new frontier. The major component of tumor stroma, the extracellular matrix (ECM), acts as a key regulator of cell and tissue function. Conventionally, the role of ECM was considered primarily as a physical scaffold that binds cells and tissues together. However, recent studies revealed the biochemical and biophysical signaling properties of the ECM as well that affect cell adhesion and migration, tissue morphogenesis and repair, and angiogenesis and cancer. The most abundant constituent of ECM, collagen, accounts for the major function of ECM, which can be associated with increased malignancy. The present review summarizes the dynamic interplay between collagen and tumor cells. It focuses on changes in physicochemical-biological properties of collagen. A new paradigm has been formulated that collagen can no more be considered playing a passive role over which tumor progression and metastasis takes place. Rather, its active role in the promotion of tumor progression and metastasis should be explored.Keywords
This publication has 22 references indexed in Scilit:
- Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancerDisease Models & Mechanisms, 2011
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 2009
- Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03Journal of Clinical Oncology, 2009
- Collagen Structure and StabilityAnnual Review of Biochemistry, 2009
- Translational medicine: science or wishful thinking?Journal of Translational Medicine, 2008
- The Myofibroblast: One Function, Multiple OriginsThe American Journal of Pathology, 2007
- Stromal Myofibroblasts Predict Disease Recurrence for Colorectal CancerClinical Cancer Research, 2007
- Formation and Function of the Myofibroblast during Tissue RepairJournal of Investigative Dermatology, 2007
- HSPG synthesis by zebrafish Ext2 and Extl3 is required for Fgf10 signalling during limb developmentDevelopment, 2005
- Stromal fibroblasts in cancer initiation and progressionNature, 2004